Transcend Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.12M | Sell |
38,379
-3,798
| -9% | -$705K | 0.55% | 39 |
|
|
2025
Q1 | $8.84M | Sell |
42,177
-883
| -2% | -$185K | 0.63% | 33 |
|
|
2024
Q4 | $7.65M | Sell |
43,060
-3,303
| -7% | -$587K | 0.55% | 39 |
|
|
2024
Q3 | $9.16M | Buy |
46,363
+136
| +0.3% | +$26.9K | 0.61% | 35 |
|
|
2024
Q2 | $7.93M | Buy |
46,227
+17,559
| +61% | +$3.01M | 0.58% | 35 |
|
|
2024
Q1 | $5.22M | Buy |
28,668
+6,775
| +31% | +$1.23M | 0.42% | 51 |
|
|
2023
Q4 | $3.39M | Sell |
21,893
-256
| -1% | -$39.7K | 0.3% | 79 |
|
|
2023
Q3 | $3.3M | Sell |
22,149
-246
| -1% | -$36.7K | 0.32% | 71 |
|
|
2023
Q2 | $3.02M | Buy |
22,395
+339
| +2% | +$45.7K | 0.29% | 84 |
|
|
2023
Q1 | $3.52M | Sell |
22,056
-415
| -2% | -$66.1K | 0.37% | 59 |
|
|
2022
Q4 | $3.63M | Sell |
22,471
-654
| -3% | -$106K | 0.39% | 57 |
|
|
2022
Q3 | $3.1M | Buy |
23,125
+132
| +0.6% | +$17.7K | 0.34% | 71 |
|
|
2022
Q2 | $3.52M | Sell |
22,993
-343
| -1% | -$52.5K | 0.37% | 63 |
|
|
2022
Q1 | $3.78M | Buy |
23,336
+813
| +4% | +$132K | 0.34% | 71 |
|
|
2021
Q4 | $3.05M | Buy |
22,523
+623
| +3% | +$84.4K | 0.27% | 98 |
|
|
2021
Q3 | $2.4M | Buy |
21,900
+2,626
| +14% | +$288K | 0.21% | 108 |
|
|
2021
Q2 | $2.17M | Buy |
19,274
+1,430
| +8% | +$161K | 0.31% | 86 |
|
|
2021
Q1 | $1.94M | Sell |
17,844
-607
| -3% | -$65.9K | 0.23% | 111 |
|
|
2020
Q4 | $1.98M | Buy |
18,451
+2,858
| +18% | +$306K | 0.26% | 102 |
|
|
2020
Q3 | $1.37M | Buy |
15,593
+1,240
| +9% | +$109K | 0.25% | 94 |
|
|
2020
Q2 | $1.41M | Sell |
14,353
-3,494
| -20% | -$343K | 0.46% | 65 |
|
|
2020
Q1 | $1.36M | Sell |
17,847
-842
| -5% | -$64.3K | 0.41% | 75 |
|
|
2019
Q4 | $1.66M | Buy |
+18,689
| New | +$1.66M | 0.45% | 71 |
|